Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2500150	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2025-06-25	Patheon Italia SpA;Recordati Netherlands BV	view
JYSB2400212	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2024-09-25	Patheon Italia SpA;Recordati Netherlands BV	view
JYSB2400167	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2024-07-30	Patheon Italia SpA;Recordati Netherlands BV	view
JYSB2400003	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2024-01-03	Patheon Italia SpA;Recordati Netherlands BV	view
JYSB2300116	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2023-07-04	Patheon Italia SpA	view
JYSB2200222	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2022-12-20	Rentschler Biopharma Se	view
JYSB2200096	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2022-06-14	Rentschler Biopharma Se	view
JYSB2200041	达妥昔单抗β注射液	dinutuximab beta	Injection	Biological Products	Supplementary Application	2022-03-15	Patheon Italia SpA;Recordati Netherlands BV	view